Prognostic value of preoperative serum tumor markers in gastric cancer

World Journal of Clinical Oncology

Volumn 5, Issue 2, 2014, Pages 170-176

  Huang, Ze Bo ^a   Zhou, Xin ^a   Xu, Jun ^a   Du, Yi Ping ^a   Zhu, Wei ^a   Wang, Jian ^a   Shu, Yong Qian ^a   Liu, Ping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer antigen 19 9; Cancer antigen 50; Carcinoembryonic antigen; Gastric cancer; Prognosis

Indexed keywords

EID: 84906827639     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i2.170     Document Type: Article

References (24)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009; 472: 467-477 [PMID: 19107449 DOI: 10.1007/978-1-60327-492-0-23]
2. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474 [PMID: 20180029 DOI: 10.1245/s10434-010-0985-4]
3. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299: 448-451 [PMID: 683276 DOI: 10.1056/NEJM197808312990904]
4. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, Mc-Clure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski VR. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 1983; 29: 549-552 [PMID: 6825270]
5. Kokociñska D, Jarzab B, Król R, Ziaja K, Szejbak K, Kusmierski S. A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers. J Environ Pathol Toxicol Oncol 1996; 15: 283-287 [PMID: 9216823]
6. Kochi M, Fujii M, Kanamori N, Kaiga T, Kawakami T, Aizaki K, Kasahara M, Mochizuki F, Kasakura Y, Yamagata M. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 2000; 3: 177-186 [PMID: 11984734]
7. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, Pinto E. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57: 55-62 [PMID: 10394126 DOI: 10.1159/000012001]
8. Park SH, Ku KB, Chung HY, Yu W. Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas. Cancer Res Treat 2008; 40: 16-21 [PMID: 19688060 DOI: 10.4143/crt.2008.40.1.16]
9. Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002; 49: 1157-1160 [PMID: 12143226]
10. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001; 32: 41-44 [PMID: 11154168]
11. Schauer M, Peiper M, Theisen J, Knoefel W. Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment. Eur J Med Res 2011; 16: 29-33 [PMID: 21345767]
12. Liu X, Cai H, Wang Y. Prognostic significance of tumor markers in T4a gastric cancer. World J Surg Oncol 2012; 10: 68 [PMID: 22540862 DOI: 10.1186/1477-7819-10-68]
13. Liu X, Cai H, Wang Y. Prognostic significance of tumour markers in Chinese patients with gastric cancer. ANZ J Surg 2012; Epub ahead of print [PMID: 23013163 DOI: 10.1111/j.1445-2197.2012.06287.x]
14. Tachibana M, Takemoto Y, Nakashima Y, Kinugasa S, Kotoh T, Dhar DK, Kohno H, Nagasue N. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. J Am Coll Surg 1998; 187: 64-68 [PMID: 9660027]
15. Duraker N, Celik AN. The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol 2001; 76: 266-271 [PMID: 11320518]
16. Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Cianetti A, Vannini P. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol 1998; 124: 450-455 [PMID: 9750022]
17. Dilege E, Mihmanli M, Demir U, Ozer K, Bostanci O, Kaya C, Aksakal O, Sakiz D. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer. Hepatogastroenterology 2010; 57: 674-677 [PMID: 20698248]
18. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, Hioki K. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994; 73: 2703-2708 [PMID: 8194009]
19. Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008; 25: 1075-1084 [PMID: 18821070 DOI: 10.1007/s12325-008-0100-4]
20. Ikeda Y, Oomori H, Koyanagi N, Mori M, Kamakura T, Minagawa S, Tateishi H, Sugimachi K. Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer. Oncology 1995; 52: 483-486 [PMID: 7478435]
21. Kiyama T, Onda M, Tokunaga A, Nishi K, Mizutani T, Yoshiyuki T, Shimizu Y, Matsukura N, Tanaka N, Asano G. Changes in serum and tissue carcinoembryonic antigen with growth of a human gastric cancer xenograft in nude mice. Jpn J Cancer Res 1990; 81: 58-62 [PMID: 2108947]
22. Choi SR, Jang JS, Lee JH, Roh MH, Kim MC, Lee WS, Qureshi W. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci 2006; 51: 2081-2086 [PMID: 17009116]
23. Gaspar MJ, Arribas I, Coca MC, Díez-Alonso M. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 2001; 22: 318-322 [PMID: 11553862]
24. Duraker N, Naci Celik A, Gençler N. The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients. Eur J Surg Oncol 2002; 28: 844-849 [PMID: 12477476]